(5aS,8aS)-7-(6-methylpyridazin-3-yl)-4-[(2-methyl-1,3-thiazol-4-yl)methyl]-3,5,5a,6,8,8a-hexahydro-2H-pyrrolo[3,4-f][1,4]oxazepine;bis(2,2,2-trifluoroacetic acid)

C21H25F6N5O5S — CID 127022308

IUPAC(5aS,8aS)-7-(6-methylpyridazin-3-yl)-4-[(2-methyl-1,3-thiazol-4-yl)methyl]-3,5,5a,6,8,8a-hexahydro-2H-pyrrolo[3,4-f][1,4]oxazepine;bis(2,2,2-trifluoroacetic acid)
SMILESCc1ccc(N2C[C@@H]3CN(Cc4csc(C)n4)CCO[C@@H]3C2)nn1.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F
InChIInChI=1S/C17H23N5OS.2C2HF3O2/c1-12-3-4-17(20-19-12)22-8-14-7-21(5-6-23-16(14)10-22)9-15-11-24-13(2)18-15;2*3-2(4,5)1(6)7/h3-4,11,14,16H,5-10H2,1-2H3;2*(H,6,7)/t14-,16+;;/m0../s1
InChIKeyMOQJMBUBUBTZHC-HSAGCVDLSA-N
MW573.52 g/mol
LogP3.15
Rot. Bonds3

About (5aS,8aS)-7-(6-methylpyridazin-3-yl)-4-[(2-methyl-1,3-thiazol-4-yl)methyl]-3,5,5a,6,8,8a-hexahydro-2H-pyrrolo[3,4-f][1,4]oxazepine;bis(2,2,2-trifluoroacetic acid)

(5aS,8aS)-7-(6-methylpyridazin-3-yl)-4-[(2-methyl-1,3-thiazol-4-yl)methyl]-3,5,5a,6,8,8a-hexahydro-2H-pyrrolo[3,4-f][1,4]oxazepine;bis(2,2,2-trifluoroacetic acid) (PubChem CID 127022308) has the molecular formula C21H25F6N5O5S and a molecular weight of 573.52 g/mol. Its IUPAC name is (5aS,8aS)-7-(6-methylpyridazin-3-yl)-4-[(2-methyl-1,3-thiazol-4-yl)methyl]-3,5,5a,6,8,8a-hexahydro-2H-pyrrolo[3,4-f][1,4]oxazepine;bis(2,2,2-trifluoroacetic acid).

Molecular Properties

Compound Name(5aS,8aS)-7-(6-methylpyridazin-3-yl)-4-[(2-methyl-1,3-thiazol-4-yl)methyl]-3,5,5a,6,8,8a-hexahydro-2H-pyrrolo[3,4-f][1,4]oxazepine;bis(2,2,2-trifluoroacetic acid)
PubChem CID127022308
Molecular FormulaC21H25F6N5O5S
Molecular Weight573.52 g/mol
Exact Mass573.15
IUPAC Name(5aS,8aS)-7-(6-methylpyridazin-3-yl)-4-[(2-methyl-1,3-thiazol-4-yl)methyl]-3,5,5a,6,8,8a-hexahydro-2H-pyrrolo[3,4-f][1,4]oxazepine;bis(2,2,2-trifluoroacetic acid)
SMILESCc1ccc(N2C[C@@H]3CN(Cc4csc(C)n4)CCO[C@@H]3C2)nn1.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F
InChIInChI=1S/C17H23N5OS.2C2HF3O2/c1-12-3-4-17(20-19-12)22-8-14-7-21(5-6-23-16(14)10-22)9-15-11-24-13(2)18-15;2*3-2(4,5)1(6)7/h3-4,11,14,16H,5-10H2,1-2H3;2*(H,6,7)/t14-,16+;;/m0../s1
InChIKeyMOQJMBUBUBTZHC-HSAGCVDLSA-N
XLogP3.15
TPSA128.98 Ų
H-Bond Donors2
H-Bond Acceptors9
Rotatable Bonds3
Heavy Atoms38
Complexity—

Lipinski Rule of Five

1 violation

RuleValue
MW ≤ 500573.52
LogP ≤ 53.15
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 109

Analyze (5aS,8aS)-7-(6-methylpyridazin-3-yl)-4-[(2-methyl-1,3-thiazol-4-yl)methyl]-3,5,5a,6,8,8a-hexahydro-2H-pyrrolo[3,4-f][1,4]oxazepine;bis(2,2,2-trifluoroacetic acid) with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of (5aS,8aS)-7-(6-methylpyridazin-3-yl)-4-[(2-methyl-1,3-thiazol-4-yl)methyl]-3,5,5a,6,8,8a-hexahydro-2H-pyrrolo[3,4-f][1,4]oxazepine;bis(2,2,2-trifluoroacetic acid)?
The IUPAC name of (5aS,8aS)-7-(6-methylpyridazin-3-yl)-4-[(2-methyl-1,3-thiazol-4-yl)methyl]-3,5,5a,6,8,8a-hexahydro-2H-pyrrolo[3,4-f][1,4]oxazepine;bis(2,2,2-trifluoroacetic acid) (CID 127022308) is (5aS,8aS)-7-(6-methylpyridazin-3-yl)-4-[(2-methyl-1,3-thiazol-4-yl)methyl]-3,5,5a,6,8,8a-hexahydro-2H-pyrrolo[3,4-f][1,4]oxazepine;bis(2,2,2-trifluoroacetic acid).
What is the SMILES notation for (5aS,8aS)-7-(6-methylpyridazin-3-yl)-4-[(2-methyl-1,3-thiazol-4-yl)methyl]-3,5,5a,6,8,8a-hexahydro-2H-pyrrolo[3,4-f][1,4]oxazepine;bis(2,2,2-trifluoroacetic acid)?
The canonical SMILES for (5aS,8aS)-7-(6-methylpyridazin-3-yl)-4-[(2-methyl-1,3-thiazol-4-yl)methyl]-3,5,5a,6,8,8a-hexahydro-2H-pyrrolo[3,4-f][1,4]oxazepine;bis(2,2,2-trifluoroacetic acid) is Cc1ccc(N2C[C@@H]3CN(Cc4csc(C)n4)CCO[C@@H]3C2)nn1.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F.
What is the InChIKey of (5aS,8aS)-7-(6-methylpyridazin-3-yl)-4-[(2-methyl-1,3-thiazol-4-yl)methyl]-3,5,5a,6,8,8a-hexahydro-2H-pyrrolo[3,4-f][1,4]oxazepine;bis(2,2,2-trifluoroacetic acid)?
The InChIKey is MOQJMBUBUBTZHC-HSAGCVDLSA-N. The full InChI is InChI=1S/C17H23N5OS.2C2HF3O2/c1-12-3-4-17(20-19-12)22-8-14-7-21(5-6-23-16(14)10-22)9-15-11-24-13(2)18-15;2*3-2(4,5)1(6)7/h3-4,11,14,16H,5-10H2,1-2H3;2*(H,6,7)/t14-,16+;;/m0../s1.
What are the key properties of (5aS,8aS)-7-(6-methylpyridazin-3-yl)-4-[(2-methyl-1,3-thiazol-4-yl)methyl]-3,5,5a,6,8,8a-hexahydro-2H-pyrrolo[3,4-f][1,4]oxazepine;bis(2,2,2-trifluoroacetic acid)?
(5aS,8aS)-7-(6-methylpyridazin-3-yl)-4-[(2-methyl-1,3-thiazol-4-yl)methyl]-3,5,5a,6,8,8a-hexahydro-2H-pyrrolo[3,4-f][1,4]oxazepine;bis(2,2,2-trifluoroacetic acid) has a molecular weight of 573.52 g/mol, XLogP of 3.15, 3 rotatable bonds, 2 hydrogen bond donors, and 9 hydrogen bond acceptors.
Where does this data come from?
All data for (5aS,8aS)-7-(6-methylpyridazin-3-yl)-4-[(2-methyl-1,3-thiazol-4-yl)methyl]-3,5,5a,6,8,8a-hexahydro-2H-pyrrolo[3,4-f][1,4]oxazepine;bis(2,2,2-trifluoroacetic acid) is sourced from PubChem (CID 127022308), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).